Human Herpesvirus 6B and Lower Respiratory Tract Disease After Hematopoietic Cell Transplantation.

PURPOSE Human herpesvirus 6B (HHV-6B) DNA is frequently detected in bronchoalveolar lavage fluid (BALF) from immunocompromised subjects with lower respiratory tract disease (LRTD). Whether HHV-6B is a pulmonary pathogen is unclear. METHODS We tested BALF for HHV-6B DNA using polymerase chain reaction in allogeneic hematopoietic cell transplantation (HCT) recipients who underwent a BAL for evaluation of LRTD from 1992 to 2015. We used multivariable proportional hazards models to evaluate the association of HHV-6B+ BALF with overall mortality, death from respiratory failure, and the effect of anti-HHV-6B antivirals on these outcomes. We used branched-chain RNA in situ hybridization to detect HHV-6 messenger RNA (U41 and U57 transcripts) in lung tissue. RESULTS We detected HHV-6B+ BALF from 147 of 553 (27%) individuals. Subjects with HHV-6B+ BALF, with or without copathogens, had significantly increased risk of overall mortality (adjusted hazard ratio [aHR], 2.18; 95% CI, 1.41-3.39) and death from respiratory failure (aHR, 2.50; 95% CI, 1.56-4.01) compared with subjects with HHV-6B- BALF. Subjects with HHV-6B+ BALF who received antivirals within 3 days pre-BAL had an approximately 1 log10 lower median HHV-6B BALF viral load, as well as a lower risk of overall mortality (aHR, 0.42; 95% CI, 0.16-1.10), compared with subjects with HHV-6B+ BALF not receiving antivirals. We detected intraparenchymal HHV-6 gene expression by RNA in situ hybridization in lung tissue in all three tested subjects with HHV-6B+ BALF and sufficient tissue RNA preservation. CONCLUSION These data provide evidence that HHV-6B detection in BALF is associated with higher mortality in allogeneic hematopoietic cell transplantation recipients with LRTD. Definitive evidence of causation will require a randomized prevention or treatment trial.

[1]  D. O’Dwyer,et al.  First Onset Herpesviral Infection and Lung Injury in Allogeneic Hematopoietic Cell Transplantation. , 2019, American journal of respiratory and critical care medicine.

[2]  K. Peggs,et al.  In vitro comparison of currently available and investigational antiviral agents against pathogenic human double‐stranded DNA viruses: A systematic literature review , 2019, Antiviral research.

[3]  S. Telford,et al.  A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  M. Boeckh,et al.  RNA Sequencing of the In Vivo Human Herpesvirus 6B Transcriptome To Identify Targets for Clinical Assays Distinguishing between Latent and Active Infections , 2018, Journal of Virology.

[5]  Michael Boeckh,et al.  Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic‐Cell Transplantation , 2017, The New England journal of medicine.

[6]  T. Miyamoto,et al.  Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation , 2017, Bone Marrow Transplantation.

[7]  W. Leisenring,et al.  Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV Pneumonia , 2017, The Journal of infectious diseases.

[8]  M. Norkin,et al.  Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. , 2016, Blood.

[9]  M. Boeckh,et al.  Detection of Human Herpesvirus 6B (HHV-6B) Reactivation in Hematopoietic Cell Transplant Recipients with Inherited Chromosomally Integrated HHV-6A by Droplet Digital PCR , 2016, Journal of Clinical Microbiology.

[10]  M. Boeckh,et al.  Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Guixia Yu,et al.  Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies. , 2015, Blood.

[12]  S. Kako,et al.  Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  E. Baron,et al.  A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  E. Baron,et al.  Executive summary: a guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). , 2013, Clinical Infectious Diseases.

[15]  F. Lowy,et al.  Diagnostic bronchoscopy in solid-organ and hematopoietic stem cell transplantation. , 2013, Annals of the American Thoracic Society.

[16]  A. Oriol,et al.  Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study , 2011, Clinical transplantation.

[17]  É. Azoulay,et al.  Significance of herpesvirus 6 in BAL fluid of hematology patients with acute respiratory failure , 2011, Infection.

[18]  Angela Panoskaltsis-Mortari,et al.  An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. , 2011, American journal of respiratory and critical care medicine.

[19]  Michael Boeckh,et al.  Reduced mortality after allogeneic hematopoietic-cell transplantation. , 2010, The New England journal of medicine.

[20]  Hermann Einsele,et al.  Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective , 2009, Biology of Blood and Marrow Transplantation.

[21]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  E. De Clercq,et al.  Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy , 2005, Clinical Microbiology Reviews.

[23]  K. Miyamura,et al.  The possible involvement of human herpesvirus type 6 in obliterative bronchiolitis after bone marrow transplantation , 2003, Bone Marrow Transplantation.

[24]  H. Deeg,et al.  Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. , 2003, Blood.

[25]  K. Ohyashiki,et al.  Detection and quantification of human herpesvirus 6 genomes using bronchoalveolar lavage fluid in immunocompromised patients with interstitial pneumonia. , 2001, International Journal of Molecular Medicine.

[26]  L. Corey,et al.  Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  S. Buchbinder,et al.  Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation , 2000, Bone Marrow Transplantation.

[28]  D. Relman,et al.  Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates , 1996, Clinical microbiology reviews.

[29]  J. Zeh,et al.  Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. , 1993, The New England journal of medicine.

[30]  D. Carrigan,et al.  Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation , 1991, The Lancet.

[31]  S. Josephs,et al.  Latent herpesvirus-6 in salivary and bronchial glands , 1990, The Lancet.

[32]  A. B. Hill.  The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[33]  A. B. Hill,et al.  "The Environment and Disease: Association or Causation?" (1965), by Austin Bradford Hill , 2017 .

[34]  J. Flanagan,et al.  RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. , 2012, The Journal of molecular diagnostics : JMD.